In tumors of the central nervous system, RUNX1 expression is significantly higher in Mesenchymal (Mes) subtype of GBM and closely related to Mes subtype initiation through microRNA (miR)-mediated mechanisms [12]. This evidence concerns the gene RUNX1 and central nervous system cancer.